Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

How artificial intelligence (AI) is transforming dermatology diagnosis and treatment

Hannah Kopelman, DO, MBA
Tech
July 10, 2023
Share
Tweet
Share

The rise of artificial intelligence (AI) is no less than a modern revolution. As we progress in the digital age, the capabilities of AI continue to expand, facilitating advancements in countless fields. One such field is health care, where AI has the potential to significantly enhance diagnostic accuracy and treatment efficiency. A shining example of this is the utilization of large language models, such as OpenAI’s Generative Pre-trained Transformer (GPT), the latest iteration being ChatGPT-4, and BERT-based models like BARD.

These AI models are becoming increasingly adept at generating text that closely mimics human-like responses. Trained on extensive datasets, they can grasp the subtleties of human language, offering nuanced, insightful, and coherent responses. But how do these AI tools translate to a specialized field like dermatology, which requires a comprehensive understanding of skin conditions and diseases? Could these AI models provide reliable solutions to dermatological concerns and even assist in clinical decision-making?

ChatGPT-4, BARD, and dermatology

The potential application of AI models like GPT-4 and BARD in dermatology is fascinating. Initial analyses hint at these AI models’ ability to offer accurate, informed responses to a majority of dermatological questions. While the current capabilities of these AI models do not yet extend to visually differentiating skin conditions that appear similar, they show immense promise in various other aspects of dermatology.

A particularly exciting possibility is their potential use in primary care. For example, ChatGPT-4 or BARD could be used as a triage service, where primary care physicians share their observations and symptoms with the AI. The AI could then assist in understanding potential diagnoses, providing initial treatment suggestions, and identifying cases that require immediate referral to a specialist.

In rural or remote areas with limited access to dermatologists, these AI models could prove instrumental. They could allow more cases to be addressed efficiently and improve early diagnosis and treatment of skin conditions. The possibility of creating such new tools for dermatologists and general physicians could change the face of dermatology and contribute to better patient outcomes.

The challenges ahead

Despite these exciting possibilities, the application of AI in dermatology presents several challenges. One key challenge is ensuring clear and accurate communication with AI models. The output of AI models like ChatGPT-4 or BARD heavily depends on the quality and clarity of the input they receive. Any ambiguity or vagueness could lead to less accurate outputs.

Moreover, while these AI models have been trained on a broad range of data, they lack access to ongoing medical research beyond their last training cut-off. This limitation underscores the need for continuous training updates to keep AI models abreast of the latest medical knowledge.

The future of AI in dermatology

The implications of AI models like ChatGPT-4 and BARD in dermatology are significant. These tools have demonstrated their ability to offer reliable responses to dermatological questions, indicating their potential as valuable clinical decision-support tools. However, it’s important to remember that while these AI models can aid in clinical decision-making, they cannot replace the nuanced judgment and experience of health care professionals.

The potential of AI in health care is immense, but careful and thoughtful implementation is crucial. Continuous evaluation of AI’s strengths, limitations, and ethical considerations will be key to maximizing its benefits, such as enhanced efficiency and accessibility, while minimizing potential risks.

As we look ahead, it’s clear that ChatGPT-4, BARD, and other large language models have an exciting role to play in the development of new dermatological tools. The potential to improve the speed and accuracy of diagnoses, enable earlier intervention, and transform the delivery of care is significant. The future is undoubtedly promising, but careful navigation is necessary to ensure these AI tools deliver on their full potential without compromising patient safety and care.

Hannah Kopelman is a dermatologist.

ADVERTISEMENT

Prev

Modern medicine is disappointing to many of us at the later end of our careers

July 10, 2023 Kevin 5
…
Next

Uncovering the truth about genetic mutations and weight loss

July 10, 2023 Kevin 0
…

Tagged as: Dermatology

Post navigation

< Previous Post
Modern medicine is disappointing to many of us at the later end of our careers
Next Post >
Uncovering the truth about genetic mutations and weight loss

ADVERTISEMENT

More by Hannah Kopelman, DO, MBA

  • Navigating the rising challenges of dermatology residency applications

    Hannah Kopelman, DO, MBA
  • Disparities in DO vs. MD applicants to subspecialties: Identifying challenges and bridging the gap

    Hannah Kopelman, DO, MBA
  • Dermatology at a crossroads: an urgent case for value-based care

    Hannah Kopelman, DO, MBA

Related Posts

  • The evolution of medical training in dermatology and the impact of technology

    Peter Lio, MD
  • How to match into dermatology: A medical student shares her success story

    Jenny Wang
  • More than skin deep: the importance of culturally competent care in medical education

    Grace Shadid
  • Cancer of the future: diagnosis, treatment, and impact on the health care system and patients

    Eugene Chan, MD
  • Stop stigmatizing medication-assisted treatment

    Brandon Jacobi
  • Don’t blame Big Pharma for insulin’s problems

    Rushi Nagalla

More in Tech

  • Why Grok 4 could be the next leap for HIPAA-compliant clinical AI

    Harvey Castro, MD, MBA
  • AI is already replacing doctors—just not how you think

    Bhargav Raman, MD, MBA
  • A mind to guide the machine: Why physicians must help shape artificial intelligence in medicine

    Shanice Spence-Miller, MD
  • How digital tools are reshaping the doctor-patient relationship

    Vineet Vishwanath
  • The promise and perils of AI in health care: Why we need better testing standards

    Max Rollwage, PhD
  • 3 tips for using AI medical scribes to save time charting

    Erica Dorn, FNP
  • Most Popular

  • Past Week

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • The One Big Beautiful Bill and the fragile heart of rural health care

      Holland Haynie, MD | Policy
    • America’s ER crisis: Why the system is collapsing from within

      Kristen Cline, BSN, RN | Conditions
    • Why timing, not surgery, determines patient survival

      Michael Karch, MD | Conditions
    • How early meetings and after-hours events penalize physician-mothers

      Samira Jeimy, MD, PhD and Menaka Pai, MD | Physician
    • FDA delays could end vital treatment for rare disease patients

      GJ van Londen, MD | Meds
  • Past 6 Months

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • The One Big Beautiful Bill and the fragile heart of rural health care

      Holland Haynie, MD | Policy
    • Why “do no harm” might be harming modern medicine

      Sabooh S. Mubbashar, MD | Physician
    • Here’s what providers really need in a modern EHR

      Laura Kohlhagen, MD, MBA | Tech
  • Recent Posts

    • Addressing menstrual health inequities in adolescents

      Callia Georgoulis | Conditions
    • How to advance workforce development through research mentorship and evidence-based management

      Olumuyiwa Bamgbade, MD | Physician
    • The truth about perfection and identity in health care

      Ryan Nadelson, MD | Physician
    • Civil discourse as a leadership competency: the case for curiosity in medicine

      All Levels Leadership | Physician
    • Healing beyond the surface: Why proper chronic wound care matters

      Alvin May, MD | Conditions
    • Why specialist pain clinics and addiction treatment services require strong primary care

      Olumuyiwa Bamgbade, MD | Conditions

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

Leave a Comment

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • The One Big Beautiful Bill and the fragile heart of rural health care

      Holland Haynie, MD | Policy
    • America’s ER crisis: Why the system is collapsing from within

      Kristen Cline, BSN, RN | Conditions
    • Why timing, not surgery, determines patient survival

      Michael Karch, MD | Conditions
    • How early meetings and after-hours events penalize physician-mothers

      Samira Jeimy, MD, PhD and Menaka Pai, MD | Physician
    • FDA delays could end vital treatment for rare disease patients

      GJ van Londen, MD | Meds
  • Past 6 Months

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • The One Big Beautiful Bill and the fragile heart of rural health care

      Holland Haynie, MD | Policy
    • Why “do no harm” might be harming modern medicine

      Sabooh S. Mubbashar, MD | Physician
    • Here’s what providers really need in a modern EHR

      Laura Kohlhagen, MD, MBA | Tech
  • Recent Posts

    • Addressing menstrual health inequities in adolescents

      Callia Georgoulis | Conditions
    • How to advance workforce development through research mentorship and evidence-based management

      Olumuyiwa Bamgbade, MD | Physician
    • The truth about perfection and identity in health care

      Ryan Nadelson, MD | Physician
    • Civil discourse as a leadership competency: the case for curiosity in medicine

      All Levels Leadership | Physician
    • Healing beyond the surface: Why proper chronic wound care matters

      Alvin May, MD | Conditions
    • Why specialist pain clinics and addiction treatment services require strong primary care

      Olumuyiwa Bamgbade, MD | Conditions

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Leave a Comment

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...